Acme United Reports Third Quarter 2026 Net Sales Increase of 18%
Acme United reported record Q3 net sales of $58.0 million, up 18% year-over-year, with comparable growth of 10% excluding the My Medic acquisition. Q3 net income rose 80% to $3.4 million, or $0.80 per diluted share, helped by a $4.0 million tariff-refund benefit to gross margin, which expanded to 45.3% from 39.1%.
Key figures
- Eps
- 0.8
- Revenue
- 58013000
- Revenue Yoy
- 18%
- Q3 net income
- 3435000
- Gross margin q3
- 45.3%
- Dmt closure cost
- 1800000
- Q3 net income yoy
- 80%
- Nine month revenue
- 173030000
- Bank debt less cash
- 29700000
- Nine month net income
- 9469000
- Nine month eps diluted
- 2.29
- Nine month revenue yoy
- 16%
- Dmt annual savings 2027
- 1000000
- Tariff refunds received
- 6000000
- Fcf trailing twelve months
- 13800000
- Gross margin prior year q3
- 39.1%
- Tariff refund recognized q3
- 4000000
- Q3 comparable sales growth ex mymedic
- 10%
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.